Delving into the Latest Updates on Jiangsu Dekang Biotechnology Co. Ltd. with Synapse

Overview

Tags

Other Diseases

Mesenchymal stem cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Mesenchymal stem cell therapy	1

Primary purpose: To clarify the safety and tolerability of DK001 in the treatment of complex anal fistulas in Crohn's disease, and to determine the safety range and recommended dose of clinical medication for subsequent trials; Secondary purpose: To preliminarily observe the effectiveness of DK001 in the treatment of complex anal fistulas in Crohn's disease, and to provide a basis for the design of subsequent confirmatory clinical trials.

Start Date10 Mar 2022

Sponsor / Collaborator

Jiangsu Dekang Biotechnology Co. Ltd.

CTR20244264

/ Not yet recruitingPhase 3

以安慰剂为对照，评价DK001治疗非活动性/轻度活动性克罗恩病复杂性肛瘘有效性和安全性的随机、双盲、多中心Ⅲ期临床试验

[Translation] A randomized, double-blind, multicenter Phase III clinical trial to evaluate the efficacy and safety of DK001 in the treatment of complex anal fistulas in inactive/mildly active Crohn's disease, using placebo as a control

与安慰剂比较，确证DK001用于治疗非活动性/轻度活动性克罗恩病成年患者的复杂性肛瘘的有效性和安全性，为DK001上市申请提供科学依据

[Translation]

Compared with placebo, the efficacy and safety of DK001 in treating complex anal fistulas in adult patients with inactive/mildly active Crohn's disease were confirmed, providing scientific basis for the DK001 marketing application

Start Date-

Sponsor / Collaborator

Jiangsu Dekang Biotechnology Co. Ltd.

100 Clinical Results associated with Jiangsu Dekang Biotechnology Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Jiangsu Dekang Biotechnology Co. Ltd.

Login to view more data

100 Deals associated with Jiangsu Dekang Biotechnology Co. Ltd.

Login to view more data

100 Translational Medicine associated with Jiangsu Dekang Biotechnology Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3

1

Login to view more data